The rs16969968 Tobacco Smoking-Related Single-Nucleotide Variant Is Associated with Clinical Markers in Patients with Severe COVID-19
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24129811 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Daniela Valencia-Pérez Rea und 7 weiteren Autor:innen. Beteiligte Einrichtung: HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Mexico. Hauptthemen laut MEDLINE: Receptors, Nicotinic, COVID-19. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas (INER).
Abstract (Originalsprache)
Tobacco smoking is the leading risk factor for many respiratory diseases. Several genes are associated with nicotine addiction, such as CHRNA5 and ADAM33. This research aims to evaluate the association of the polymorphisms rs16969968 (CHRNA5) and rs3918396 (ADAM33) in patients who developed severe COVID-19. We included 917 COVID-19 patients hospitalized with critical disease and oxygenation impairment. They were divided into two groups, tobacco-smoking (n = 257) and non-smoker (n = 660) patients. The genotype and allele frequencies of two single nucleotide variants, the rs16969968 (CHRNA5) and rs3918396 (ADAM33), were evaluated. The rs3918396 in ADAM33 does not show a significative association. We analyzed the study population according to the rs16969968 genotype (GA + AA, n = 180, and GG, n = 737). The erythrocyte sedimentation rate (ESR) shows statistical differences; the GA + AA group had higher values than the GG group (p = 0.038, 32 vs. 26 mm/h, respectively). The smoking patients and GA or AA genotype carriers had a high positive correlation (p < 0.001, rho = 0.753) between fibrinogen and C-reactive protein. COVID-19 patients and smokers carriers of one or two copies of the risk allele (rs16969968/A) have high ESR and a positive correlation between fibrinogen and C-reactive protein.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Mexico.
- Translational Research Laboratory on Aging and Pulmonary Fibrosis, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Mexico.
- Laboratory of Integrative Immunology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Mexico.
ORCID-Profile: Ramcés Falfán-Valencia, Ingrid Fricke-Galindo, Ivette Buendía-Roldán, Leslie Chávez-Galán, Jesús Alanis-Ponce, Gloria Pérez-Rubio
Förderung
- Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas (INER)
Zitieren
APA
Valencia-Pérez Rea, D., Falfán-Valencia, R., Fricke-Galindo, I., Buendía-Roldán, I., Chávez-Galán, L., Nava-Quiroz, K. J., Alanis-Ponce, J., & Pérez-Rubio, G. (2023). The rs16969968 Tobacco Smoking-Related Single-Nucleotide Variant Is Associated with Clinical Markers in Patients with Severe COVID-19. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24129811
Vancouver
Valencia-Pérez Rea D, Falfán-Valencia R, Fricke-Galindo I, Buendía-Roldán I, Chávez-Galán L, Nava-Quiroz KJ, et al. The rs16969968 Tobacco Smoking-Related Single-Nucleotide Variant Is Associated with Clinical Markers in Patients with Severe COVID-19. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24129811
BibTeX
@article{ValenciaPrezRea2023,
author = {Valencia-Pérez Rea, Daniela and Falfán-Valencia, Ramcés and Fricke-Galindo, Ingrid and Buendía-Roldán, Ivette and Chávez-Galán, Leslie and Nava-Quiroz, Karol J and Alanis-Ponce, Jesús and Pérez-Rubio, Gloria},
title = {The rs16969968 Tobacco Smoking-Related Single-Nucleotide Variant Is Associated with Clinical Markers in Patients with Severe COVID-19},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24129811}
}
EUVIMED